Yüklüyor......
Impact of bosentan on health-related quality of life and dyspnoea in idiopathic pulmonary fibrosis: the BUILD-1 trial
OBJECTIVE: No therapy is known to improve health-related quality of life (HRQL) or dyspnoea in patients with idiopathic pulmonary fibrosis (IPF). This study investigated longitudinal changes in HRQL and dyspnoea and explored the effects of bosentan on these endpoints during the BUILD-1 trial. METHOD...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848824/ https://ncbi.nlm.nih.gov/pubmed/19679600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00188108 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|